US › Healthcare

Quantum BioPharma Ltd. (QNTM)

US · Healthcare · Biotechnology

$3.72+1.92%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-3.2M

EPS

$-0.47

EPS estimate

$-0.59

EPS came in at -0.47 against a street estimate of -0.59 — a beat of 20.3%.

Key statistics

Market cap

$20.6M

Forward P/E

0.0

P/B

0.00

Book value

$1.05

EPS (TTM)

$-4.49

52-week high

$21.00

52-week low

$2.07

50-day MA

$3.23

200-day MA

$4.85

Beta

0.45

Analyst view

with an average price target of $12.58.

Shareholding

Insiders

8.40%

Institutions

9.61%

Largest institutional holders

Fund	Stake
Group One Trading, LLC	80.95%
AdvisorShares Investments, LLC	0.00%
Platform Technology Partners	0.00%
Jane Street Group LLC	0.00%
Citadel Advisors Llc	0.00%
Marex Group Ltd	0.00%
Virtu Financial LLC	0.00%
Mariner Wealth Advisors LLC	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Quantum BioPharma Ltd. — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.